SentinelOne is making a major push this year around AI-powered SIEM, as well as cloud and data security, Channel Chief Brian ...

Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine. New Drug Application (NDA) Submission Expected in the ...

"At Scientel, we serve clients across a variety of industries and look to provide comprehensive solutions to the complex ...

In recent years, the broader technology sector has often been the driving force behind market growth. However, at the start ...